For patients with early multinodular hepatocellular carcinoma (HCC) who are ineligible for liver transplant, liver resection provides a survival advantage over percutaneous radiofrequency ablation and ...

Liver resection should be the primary therapeutic option for patients with early multinodular hepatocellular carcinoma (HCC) who are ineligible for transplant, a retrospective cohort study suggested.

A risky but often lifesaving surgery that removes damaged parts of the small intestine can leave patients facing a new threat ...

High preoperative HBsAg levels are associated with increased recurrence risk after curative resection for HBV-related HCC.

Resection of liver metastases is considered the only treatment with curative potential for patients with metastatic colorectal cancer to the liver (CRLM). However, only a minority of patients with ...

In this retrospective cohort study, liver resection (LR) showed higher 1-, 3-, and 5-year survival rates than percutaneous radiofrequency ablation (PRFA) or transarterial chemoembolization (TACE).

Approximately 25% of patients with colorectal cancer present with metastatic disease to the liver at diagnosis, and about 50% develop liver metastases at some point during the course of the disease.

Patients with colorectal cancer (CRC) liver metastases had reduced risk of intrahepatic recurrence when using intraoperative contrast-enhanced ultrasounds. A new study published in Digestive and Liver ...